- About Us
- Contact
- Editorial Staff
- Editorial Boards
- Advertise
- Do Not Sell My Information
- Terms & Conditions
- Privacy Policy
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Pontchartrain Cancer Center
Latest from Pontchartrain Cancer Center
In Reversal, FTC Launches Inquiry Into PBM Industry
June 08, 2022
Article
As part of its inquiry, the Federal Trade Commission (FTC) will demand that the 6 largest pharmacy benefit managers (PBMs) submit records and answer questions regarding their business practices.
Contributor: It’s Time for Drug Middlemen to Own Up and Pass the Savings to Consumers
May 23, 2022
Article
The dysfunction with pharmacy benefit managers (PBMs) is so troublesome that the Federal Trade Commission (FTC) is currently investigating how they have driven up costs. Until May 25, the FTC is holding a public comment period on PBM practices.
Why White Bagging Is a Symptom of High Drug Costs, and What States Are Doing
April 03, 2022
Article
Many oncologists oppose white bagging because they prefer to be able to adjust doses during a visit based on lab reports taken that day.
Kathy Oubre on Challenges, Benefits of Biosimilar Integration in Oncology
April 08, 2021
Video
Kathy Oubre, MS, chief operating officer of Pontchartrain Cancer Center, discusses cost-saving implications of biosimilars in oncology, as well as several barriers that continue to impede their use.
Kathy Oubre Previews Biosimilar Discussion at the 2021 Community Oncology Alliance
April 01, 2021
Video
Kathy Oubre, MS, chief operating officer, Pontchartrain Cancer Center, explores US adoption of biosimilars ahead of her panel discussion at the 2021 Community Oncology Conference, as well as what sessions she’s looking forward to attending.
Webinar: How Biosimilar Rebates Shape Payer Policies, Provider Behavior
September 25, 2020
Webinar
More biosimilars are hitting the US market, but marketplace dynamics have made it difficult to take advantage of these therapies.
The Road to VBC for a Small Community Oncology Practice
September 17, 2020
Article
In the past 5 years, a community-based cancer clinic has undergone a large degree of change to achieve its goals of practice transformation and value-based care (VBC).
Kathy Oubre on Challenges, Solutions to Addressing Clinical Trial Participation
April 21, 2020
Video
The clinicians and nurses at Pontchartrain Cancer Center address the education behind the clinical trials, which helps patients understand that they can have access to cutting edge therapy that they would not otherwise have access to, said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center. Kathy Oubre is additionally scheduled to speak at the Community Oncology Alliance Virtual Meeting, which runs from April 23-24, 2020.
Kathy Oubre Discusses How Tailored Education Programs Assist in Optimizing Cancer Care for Patients
April 10, 2020
Video
Developing an expansive program to meet the needs of all of our patients, at all education levels, is 1 of the biggest challenges we face at Pontchartrain Cancer Center, said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center. Kathy Oubre is additionally scheduled to speak at the Community Oncology Alliance Virtual Meeting, which runs from April 23-24, 2020.